News | May 17, 2010

Organization Promotes Quality Care in Cath Labs

May 17, 2010 – The Society for Cardiovascular Angiography and Interventions (SCAI) recently announced the creation of the Accreditation for Cardiovascular Excellence (ACE) organization. The new accrediting body, announced at SCAI’s 33rd Annual Scientific Sessions in early May, is designed to promote and uphold high-quality patient care and improve patient safety in facilities where invasive cardiac and endovascular procedures are performed.

ACE will advance excellence by providing an accrediting mechanism, based on scientific evidence in peer-reviewed medical literature and professionally determined quality metrics, to ensure processes and outcomes of cardiovascular procedures are consistent with predetermined benchmarks. ACE also makes available tools and quality improvement guidance to organizations seeking, or having achieved provisional accreditation, in order to support ongoing quality improvement and optimal patient care.

“Our primary goal for ACE is to increase the consistency of superior patient care in cardiovascular procedures throughout the U.S.,” said Bonnie Weiner, M.D., MSEC, MBA, FSCAI, president of ACE and director of interventional cardiology research at Saint Vincent Hospital at Worcester Medical Center, Worcester, Mass. “When they are treated at a cardiovascular center that is ACE-accredited, patients should feel confident the facility has taken the appropriate, evidence-based steps to help ensure the best care for each individual patient.”

Carotid Stenting
ACE will first focus on providing accreditation to hospitals that perform carotid artery stenting procedures, with subsequent expansion to other cardiovascular procedures, including percutaneous coronary interventions, other endovascular procedures and structural heart disease interventions. Currently, carotid artery stenting is reserved primarily for patients who are at high-risk for carotid endarderectomy.

“Advancing quality standards is of utmost importance in our field and in all of medicine,” said Steven R. Bailey, M.D., FSCAI, chief, division of cardiology, Janey Briscoe distinguished chair of cardiovascular research and professor of medicine and radiology at the University of Texas Health Sciences Center at San Antonio and SCAI president. “ACE will help us to work proactively to promote and maintain excellence for the patients we serve.”

ACE will begin accrediting carotid artery stenting facilities this summer. Facilities must apply for accreditation, submit data and be visited by review teams to complete the process. Part of the accreditation process will include validation of self-reported data and appropriate use of existing guidelines and knowledge of changing best practices. Accreditation will last for a two-year period, after which a review of the facility will be required for continued ACE recognition.

For more information: www.cvexcel.org

Related Content

Philips Showcases Integrated Solutions for Cardiovascular Care at TCT 2018
News | Cath Lab | September 20, 2018
At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego, Philips is showcasing...
Sponsored Content | Videos | Cath Lab | September 19, 2018
William O’Neill, M.D., outlines his recent clinical publication of AMICS patients from the Impella Quality (IQ) datab
Videos | Cath Lab | September 14, 2018
A discussion with Nicolas Bevins, Ph.D., vice chair, physics and research, and Jessica Harrington, RCIS.
A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. DAIC staff photo by Dave Fornell

A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. (right) who is proctoring a fellow in treating CTOs.

Feature | Cath Lab | September 13, 2018 | Artur Kim, Kamran Zamanian
Coronary artery disease (CAD) is a multifaceted disease that demands various approaches in terms of diagnosis and tre
Videos | Cath Lab | August 13, 2018
Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and Vascul
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
FFR software on the GE Centricity CVIS. A trial from the 2018 EuroPCR meeting showed FFR improves long-term outcomes.
News | Cath Lab | May 29, 2018
May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable c
SCAI Updates Consensus on Length of Stay for Percutaneous Coronary Intervention
News | Cath Lab | May 15, 2018
Revised guidelines incorporating new data on discharge criteria for patients undergoing elective percutaneous coronary...
No Benefit Found Using Sodium Bicarbonate, Acetylcysteine to Prevent Kidney Injury, the result of the PRESERVE Trial to prevent acute kidney injury (AKI), presented at SCAI 2018.  #SCAI, #SCAI2018,
Feature | Cath Lab | May 15, 2018
May 15, 2018 – The large-scale, international randomized PRESERVE clinical trial found high-risk patients for renal c
Angiogram of a STEMI patient.
News | Cath Lab | May 15, 2018
May 15, 2018 — A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is used
Overlay Init